Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco.

asymptomatic SARS-CoV-2 infection community-based SARS-CoV-2 testing ethnic disparities phylogenetic analysis shelter-in-place

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
30 07 2021
Historique:
received: 14 07 2020
accepted: 17 08 2020
pubmed: 22 8 2020
medline: 5 8 2021
entrez: 22 8 2020
Statut: ppublish

Résumé

There is an urgent need to understand the dynamics and risk factors driving ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission during shelter-in-place mandates. We offered SARS-CoV-2 reverse-transcription polymerase chain reaction (PCR) and antibody (Abbott ARCHITECT IgG) testing, regardless of symptoms, to all residents (aged ≥4 years) and workers in a San Francisco census tract (population: 5174) at outdoor, community-mobilized events over 4 days. We estimated SARS-CoV-2 point prevalence (PCR positive) and cumulative incidence (antibody or PCR positive) in the census tract and evaluated risk factors for recent (PCR positive/antibody negative) vs prior infection (antibody positive/PCR negative). SARS-CoV-2 genome recovery and phylogenetics were used to measure viral strain diversity, establish viral lineages present, and estimate number of introductions. We tested 3953 persons (40% Latinx; 41% White; 9% Asian/Pacific Islander; and 2% Black). Overall, 2.1% (83/3871) tested PCR positive: 95% were Latinx and 52% were asymptomatic when tested; 1.7% of census tract residents and 6.0% of workers (non-census tract residents) were PCR positive. Among 2598 tract residents, estimated point prevalence of PCR positives was 2.3% (95% confidence interval [CI], 1.2%-3.8%): 3.9% (95% CI, 2.0%-6.4%) among Latinx persons vs 0.2% (95% CI, .0-.4%) among non-Latinx persons. Estimated cumulative incidence among residents was 6.1% (95% CI, 4.0%-8.6%). Prior infections were 67% Latinx, 16% White, and 17% other ethnicities. Among recent infections, 96% were Latinx. Risk factors for recent infection were Latinx ethnicity, inability to shelter in place and maintain income, frontline service work, unemployment, and household income <$50 000/year. Five SARS-CoV-2 phylogenetic lineages were detected. SARS-CoV-2 infections from diverse lineages continued circulating among low-income, Latinx persons unable to work from home and maintain income during San Francisco's shelter-in-place ordinance.

Sections du résumé

BACKGROUND
There is an urgent need to understand the dynamics and risk factors driving ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission during shelter-in-place mandates.
METHODS
We offered SARS-CoV-2 reverse-transcription polymerase chain reaction (PCR) and antibody (Abbott ARCHITECT IgG) testing, regardless of symptoms, to all residents (aged ≥4 years) and workers in a San Francisco census tract (population: 5174) at outdoor, community-mobilized events over 4 days. We estimated SARS-CoV-2 point prevalence (PCR positive) and cumulative incidence (antibody or PCR positive) in the census tract and evaluated risk factors for recent (PCR positive/antibody negative) vs prior infection (antibody positive/PCR negative). SARS-CoV-2 genome recovery and phylogenetics were used to measure viral strain diversity, establish viral lineages present, and estimate number of introductions.
RESULTS
We tested 3953 persons (40% Latinx; 41% White; 9% Asian/Pacific Islander; and 2% Black). Overall, 2.1% (83/3871) tested PCR positive: 95% were Latinx and 52% were asymptomatic when tested; 1.7% of census tract residents and 6.0% of workers (non-census tract residents) were PCR positive. Among 2598 tract residents, estimated point prevalence of PCR positives was 2.3% (95% confidence interval [CI], 1.2%-3.8%): 3.9% (95% CI, 2.0%-6.4%) among Latinx persons vs 0.2% (95% CI, .0-.4%) among non-Latinx persons. Estimated cumulative incidence among residents was 6.1% (95% CI, 4.0%-8.6%). Prior infections were 67% Latinx, 16% White, and 17% other ethnicities. Among recent infections, 96% were Latinx. Risk factors for recent infection were Latinx ethnicity, inability to shelter in place and maintain income, frontline service work, unemployment, and household income <$50 000/year. Five SARS-CoV-2 phylogenetic lineages were detected.
CONCLUSIONS
SARS-CoV-2 infections from diverse lineages continued circulating among low-income, Latinx persons unable to work from home and maintain income during San Francisco's shelter-in-place ordinance.

Identifiants

pubmed: 32821935
pii: 5895337
doi: 10.1093/cid/ciaa1234
pmc: PMC7499499
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S127-S135

Subventions

Organisme : NIAID NIH HHS
ID : K24 AI144048
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007641
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI060530
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069496
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Gabriel Chamie (G)

University of California, San Francisco, San Francisco, California, USA.

Carina Marquez (C)

University of California, San Francisco, San Francisco, California, USA.

Emily Crawford (E)

University of California, San Francisco, San Francisco, California, USA.
Chan Zuckerberg Biohub, San Francisco, California, USA.

James Peng (J)

University of California, San Francisco, San Francisco, California, USA.

Maya Petersen (M)

University of California, Berkeley, Berkeley, California, USA.

Daniel Schwab (D)

College of the Holy Cross, Worcester, Massachusetts, USA.

Joshua Schwab (J)

University of California, Berkeley, Berkeley, California, USA.

Jackie Martinez (J)

University of California, San Francisco, San Francisco, California, USA.

Diane Jones (D)

Unidos en Salud/United in Health, San Francisco, California, USA.

Douglas Black (D)

University of California, San Francisco, San Francisco, California, USA.

Monica Gandhi (M)

University of California, San Francisco, San Francisco, California, USA.

Andrew D Kerkhoff (AD)

University of California, San Francisco, San Francisco, California, USA.

Vivek Jain (V)

University of California, San Francisco, San Francisco, California, USA.

Francesco Sergi (F)

University of California, San Francisco, San Francisco, California, USA.

Jon Jacobo (J)

Latino Task Force for COVID-19, San Francisco, California, USA.

Susana Rojas (S)

Latino Task Force for COVID-19, San Francisco, California, USA.

Valerie Tulier-Laiwa (V)

Latino Task Force for COVID-19, San Francisco, California, USA.

Tracy Gallardo-Brown (T)

Latino Task Force for COVID-19, San Francisco, California, USA.

Ayesha Appa (A)

University of California, San Francisco, San Francisco, California, USA.

Charles Chiu (C)

University of California, San Francisco, San Francisco, California, USA.

Mary Rodgers (M)

Abbott Laboratories, Abbott Park, Illinois, USA.

John Hackett (J)

Abbott Laboratories, Abbott Park, Illinois, USA.

Amy Kistler (A)

Chan Zuckerberg Biohub, San Francisco, California, USA.

Samantha Hao (S)

Chan Zuckerberg Biohub, San Francisco, California, USA.

Jack Kamm (J)

Chan Zuckerberg Biohub, San Francisco, California, USA.

David Dynerman (D)

Chan Zuckerberg Biohub, San Francisco, California, USA.

Joshua Batson (J)

Chan Zuckerberg Biohub, San Francisco, California, USA.

Bryan Greenhouse (B)

University of California, San Francisco, San Francisco, California, USA.

Joe DeRisi (J)

University of California, San Francisco, San Francisco, California, USA.
Chan Zuckerberg Biohub, San Francisco, California, USA.

Diane V Havlir (DV)

University of California, San Francisco, San Francisco, California, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH